TrademarkDir
ENBRAFY
DEAD

Serial Number

87077422

Owner

Array BioPharma Inc.

Attorney

Cynthia Johnson Walden

Filing Date

Jun 20, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ENBRAFY Trademark

Serial Number: 87077422

ENBRAFY is a trademark filed by Array BioPharma Inc. on June 20, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Array BioPharma Inc. (29 trademarks)

Boulder, CO 80301

Entity Type: 03

Trademark Details

Filing Date

June 20, 2016

Registration Date

Not Registered

Published for Opposition

October 25, 2016

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jan 21, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jan 20, 2020 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2019 EXRA
SOU EXTENSION 5 GRANTED
May 14, 2019 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 10, 2019 AITU
SOU EXTENSION 5 FILED
May 7, 2019 EXT5
SOU TEAS EXTENSION RECEIVED
May 7, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 22, 2018 EXRA
SOU EXTENSION 4 GRANTED
Dec 20, 2018 EX4G
SOU EXTENSION 4 FILED
Dec 20, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Dec 20, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 20, 2018 EXRA
SOU EXTENSION 3 GRANTED
Jun 18, 2018 EX3G
SOU EXTENSION 3 FILED
Jun 18, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 18, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 7, 2017 EXRA
SOU EXTENSION 2 GRANTED
Dec 5, 2017 EX2G
SOU EXTENSION 2 FILED
Dec 5, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 5, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 16, 2017 EXRA
SOU EXTENSION 1 GRANTED
May 12, 2017 EX1G
SOU EXTENSION 1 FILED
May 12, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
May 12, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2016 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 15, 2016 CNSA
ASSIGNED TO EXAMINER
Sep 15, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2016 NWOS
NEW APPLICATION ENTERED
Jun 23, 2016 NWAP

Related Trademarks

More from this Owner

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI

MEKTOVI